Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05547321
Title Efficacy and Safety Study of OMTX705, Monotherapy and Pembrolizumab-combined, in Subjects With Advanced Solid Tumors.
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncomatryx Biopharma S.L.


head and neck squamous cell carcinoma

ovary serous adenocarcinoma

breast cancer

Advanced Solid Tumor

pancreatic ductal adenocarcinoma

colorectal cancer

stomach cancer

lung non-small cell carcinoma

esophageal cancer


OMTX705 + Pembrolizumab


Age Groups: senior | adult
Covered Countries USA | ESP

No variant requirements are available.